Application of the joined wing to tiltrotor aircraft

A study was made to determine the potential speed improvements and other benefits resulting from the application of the joined wing concept to tiltrotor aircraft. Using the XV-15 as a baseline, the effect of replacing the cantilever wing by a joined-wing pair was studied. The baseline XV-15 cantilever wing has a thickness/chord ratio of 23 percent. It was found that this wing could be replaced by a joined-wing pair of the same span and total area employing airfoils of 12 percent thickness/chord ratio. The joined wing meets the same static strength requirements as the cantilever wing, but increases the limiting Mach Number of the aircraft from M=0.575 to M=0.75, equivalent to an increase of over 100 knots in maximum speed. The joined wing configuration studied is lighter than the cantilever and has approximately 11 percent less wing drag in cruise. Its flutter speed of 245 knots EAS is not high enough to allow the potential Mach number improvement to be attained at low altitude. The flutter speed can be raised either by employing rotors which can be stopped and folded in flight at speeds below 245 knots EAS, or by modifying the airframe to reduce adverse coupling with the rotor dynamics. Several modifications of wing geometry and nacelle mass distribution were investigated, but none produced a flutter speed above 260 knots EAS. It was concluded that additional research is required to achieve a more complete understanding of the mechanism of rotor/wing coupling

Integrated technology wing design study

The technology development costs and associated benefits in applying advanced technology associated with the design of a new wing for a new or derivative trijet with a capacity for 350 passengers and maximum range of 8519 km, entering service in 1990 were studied. The areas of technology are: (1) airfoil technology; (2) planform parameters; (3) high lift; (4) pitch active control system; (5) all electric systems; (6) E to 3rd power propulsion; (7) airframe/propulsion integration; (8) graphite/epoxy composites; (9) advanced aluminum alloys; (10) titanium alloys; and (11) silicon carbide/aluminum composites. These technologies were applied to the reference aircraft configuration. Payoffs were determined for block fuel reductions and net value of technology. These technologies are ranked for the ratio of net value of technology (NVT) to technology development costs

Evidence for the utilization of host tRNA(m5 U)methylase to modify tRNA coded by phage T4

Mutants of Escherichia coli defective only in the biosynthesis of 5-methyluridine (ribothymidine) in their transfer ribonucleic acid (tRNA) were employed to investigate whether phage T4 induces its own tRNA (m5U)methylase and whether T4-specific tRNA contains 5-methyluridine. The amounts of other methylated derivatives in the T4-specific tRNA were also determined. The results establish that T4-specific tRNA contains 5-methyluridine, and that there is an absolute requirement for a functional host tRNA(m5U)methylase to undertake this modification. Comparison of several physical properties of the host enzyme before and after phage T4 infection did not suggest any phage-directed alteration of the enzyme. The distribution of the methylated constituents in T4-specific tRNA is distinguishable from that in host tRNA. This change, however, may simply reflect a different population of tRNA chains produced by the T4 phage, rather than some change in the tRNA methylase activity of the host.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/33911/1/0000176.pd

ジペプチジルペプチターゼ4阻害剤（シタグリプチン）およびアンギオテンシンⅡ1型受容体遮断薬（ロサルタン）の併用療法は非糖尿病ラットモデルにおける非アルコール性脂肪肝炎の進行を抑制する

AIM: Dipeptidyl peptidase-4 (DPP4) inhibitors (DPP4-I) are oral glucose-lowering drugs for type 2 diabetes mellitus. Previously, we reported that DPP4-I (sitagliptin) exerted suppressive effects on experimental liver fibrosis in rats. Blockade of the renin-angiotensin system by angiotensin-II type 1 receptor blocker (losartan), commonly used in the management of hypertension, has been shown to significantly alleviate hepatic fibrogenesis and carcinogenesis. We aimed to elucidate the effects and possible mechanisms of a sitagliptin + losartan combination on the progression of non-diabetic non-alcoholic steatohepatitis (NASH) in a rat model. METHODS: To induce NASH, Fischer 344 rats were fed a choline-deficient L-amino acid-defined diet for 12 weeks. We elucidated the chemopreventive effects of sitagliptin + losartan, especially in conjunction with hepatic stellate cell (HSC) activation, angiogenesis, and oxidative stress, all known to play important roles in the progression of NASH. RESULTS: Sitagliptin + losartan suppressed choline-deficient L-amino acid-defined diet-induced hepatic fibrogenesis and carcinogenesis. The combination treatment exerted a greater inhibitory effect than monotherapy. These inhibitory effects occurred almost concurrently with the suppression of HSC activation, neovascularization, and oxidative stress. In vitro studies showed that sitagliptin + losartan inhibited angiotensin II-induced proliferation and expression of transforming growth factor-β1 and α1 (I)-procollagen mRNA of activated HSC and in vitro angiogenesis, in parallel with the suppression observed in in vivo studies. CONCLUSIONS: The widely and safely used sitagliptin + losartan combination treatment in clinical practice could be an effective strategy against NASH.博士（医学）・乙第1406号・平成29年9月27日© 2016 The Japan Society of HepatologyCopyright © 2016 John Wiley & Sons, Inc. All Rights Reserved.This is the pre-peer reviewed version of the following article: Hepatology research [Epub ahead of print] (2016 Dec 28), which has been published in final form at http://dx.doi.org/10.1111/hepr.12860. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving

Photoionization and photoabsorption cross sections for ionospheric calculations

Photoionization and photoabsorption cross sections for N2, O2 and O are presented in a form useful for calculation of solar EUV absorption and photoelectron production. The cross sections are based mostly on the data presented in the reviews by (1969) and (1969).Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/34031/1/0000308.pd

Biotransformation of 9-[beta]-d-arabinofurano-syladenine by rat and human erythrocytes

Studies were performed to test whether 9-[beta]--arabinofuranosyladenine (ara-A) would accumulate in erythrocytes as a result of phosphorylation to the nucleotide level. When [3H]ara-A was incubated with whole blood from rat, monkey or man for 2 hr at 37[deg], the drug rapidly equilibrated between erythrocytes and plasma but did not concentrate in the cells. Incubation of [3H]ara-A with rat and human erythrocyte lysates for 2 hr followed by Chromatographie analysis showed that 2-5 per cent of ara-A was converted to nucleotides. In contrast, 10-35 per cent of [14C]adenosine was converted to adenine nucleotides under the same conditions. Incubation of [3H]ara-A with human erythrocyte lysates for 18 hr resulted in a conversion of approx. 40 per cent of the labeled drug to nucleotides. Additional chromatography revealed, however, that the nucleotide fraction contained almost no arabinosyl nucleotides. Rather, 90 per cent of the label in the nucleotide fraction was identified as IMP. These results indicate that only a minor amount, if any, of ara-A was phosphorylated by erythrocyte enzymes to yield arabinosyl nucleotides. An alternative pathway converted much of the labeled drug to ribosyl nucleotides via the deamination of ara-A to ara-hypoxanthine, cleavage to hypoxanthine and conversion of the free hypoxanthine to IMP.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/22270/1/0000709.pd

Conducting Online Expert panels: a feasibility and experimental replicability study

<p>Abstract</p> <p>Background</p> <p>This paper has two goals. First, we explore the feasibility of conducting online expert panels to facilitate consensus finding among a large number of geographically distributed stakeholders. Second, we test the replicability of panel findings across four panels of different size.</p> <p>Method</p> <p>We engaged 119 panelists in an iterative process to identify definitional features of Continuous Quality Improvement (CQI). We conducted four parallel online panels of different size through three one-week phases by using the RAND's ExpertLens process. In Phase I, participants rated potentially definitional CQI features. In Phase II, they discussed rating results online, using asynchronous, anonymous discussion boards. In Phase III, panelists re-rated Phase I features and reported on their experiences as participants.</p> <p>Results</p> <p>66% of invited experts participated in all three phases. 62% of Phase I participants contributed to Phase II discussions and 87% of them completed Phase III. Panel disagreement, measured by the mean absolute deviation from the median (MAD-M), decreased after group feedback and discussion in 36 out of 43 judgments about CQI features. Agreement between the four panels after Phase III was fair (four-way kappa = 0.36); they agreed on the status of five out of eleven CQI features. Results of the post-completion survey suggest that participants were generally satisfied with the online process. Compared to participants in smaller panels, those in larger panels were more likely to agree that they had debated each others' view points.</p> <p>Conclusion</p> <p>It is feasible to conduct online expert panels intended to facilitate consensus finding among geographically distributed participants. The online approach may be practical for engaging large and diverse groups of stakeholders around a range of health services research topics and can help conduct multiple parallel panels to test for the reproducibility of panel conclusions.</p

MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer

Two common mutations, 677 C→T and a1298 A→C, in the methylenetetrahydrofolate reductase gene (MTHFR) reduce the activity of MTHFR and folate metabolism. Familial aggregation in a variable but significant proportion of gastric cancer (GC) cases suggests the importance of genetic predisposition in determining risk. In this study, we evaluate MTHFR polymorphisms in 57 patients with a diagnosis of GC, in 37 with a history of GC in first-degree relatives (GC-relatives), and in 454 blood donors. Helicobacter pylori (HP) infection was also determined. An increased risk was found for 677TT in GC patients with respect to blood donors (odds ratio (OR) = 1.98), and statistical significance was sustained when we compared sex–age-matched GC patients and donors (OR = 2.37). The 677TT genotype association with GC was found in women (OR = 3.10), while a reduction in the 667C allele frequency was present in both the sex. No statistically significant association was detected when 677–1298 genotype was stratified by sex and age. Men of GC-relatives showed a higher 1298C allele frequency than donors (OR = 4.38). Between GC and GC-relatives, HP infection frequency was similar. In conclusion, overall findings support the hypothesis that folate plays a role in GC risk. GC-relatives evidence a similar 677TT frequency to that found in the general population

Serum folate, homocysteine and colorectal cancer risk in women: a nested case–control study

Accumulating evidence suggests that folate, which is plentiful in vegetables and fruits, may be protective against colorectal cancer. The authors have studied the relationship of baseline levels of serum folate and homocysteine to the subsequent risk of colorectal cancer in a nested case–control study including 105 cases and 523 matched controls from the New York University Women's Health Study cohort. In univariate analyses, the cases had lower serum folate and higher serum homocysteine levels than controls. The difference was more significant for folate (P < 0.001) than for homocysteine (P = 0.04). After ad'justing for potential confounders, the risk of colorectal cancer in the subjects in the highest quartile of serum folate was half that of those in the lowest quartile (odds ratio, OR = 0.52, 95% confidence interval, CI = 0.27–0.97, P-value for trend = 0.04). The OR for the highest quartile of homocysteine, relative to the lowest quartile, was 1.72 (95% CI = 0.83–3.65, P-value for trend = 0.09). In addition, the risk of colorectal cancer was almost twice as high in subjects with below-median serum folate and above-median total alcohol intake compared with those with above-median serum folate and below-median alcohol consumption (OR = 1.99, 95% CI = 0.92–4.29). The potentially protective effects of folate need to be confirmed in clinical trials. © 1999 Cancer Research Campaig